A detailed history of Acadian Asset Management LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Acadian Asset Management LLC holds 325,945 shares of RDY stock, worth $5.03 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
325,945
Previous 269,131 21.11%
Holding current value
$5.03 Million
Previous $20.5 Million 26.29%
% of portfolio
0.08%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$75.41 - $84.21 $4.28 Million - $4.78 Million
56,814 Added 21.11%
325,945 $25.9 Million
Q2 2024

Aug 06, 2024

BUY
$68.26 - $76.19 $4.98 Million - $5.56 Million
72,978 Added 37.2%
269,131 $20.5 Million
Q1 2024

May 10, 2024

SELL
$67.36 - $77.59 $1.02 Million - $1.18 Million
-15,168 Reduced 7.18%
196,153 $14.4 Million
Q4 2023

Feb 13, 2024

SELL
$64.27 - $69.9 $3.79 Million - $4.12 Million
-58,939 Reduced 21.81%
211,321 $14.7 Million
Q3 2023

Nov 13, 2023

BUY
$61.9 - $72.77 $3.55 Million - $4.17 Million
57,293 Added 26.9%
270,260 $18.1 Million
Q2 2023

Aug 07, 2023

BUY
$53.34 - $63.11 $606,955 - $718,128
11,379 Added 5.64%
212,967 $13.4 Million
Q1 2023

May 11, 2023

BUY
$51.63 - $56.93 $3.98 Million - $4.39 Million
77,125 Added 61.97%
201,588 $11.5 Million
Q4 2022

Feb 14, 2023

BUY
$51.15 - $57.45 $966,990 - $1.09 Million
18,905 Added 17.91%
124,463 $6.44 Million
Q3 2022

Nov 14, 2022

BUY
$49.9 - $57.32 $486,425 - $558,755
9,748 Added 10.17%
105,558 $5.52 Million
Q2 2022

Aug 09, 2022

SELL
$49.62 - $58.13 $706,787 - $828,003
-14,244 Reduced 12.94%
95,810 $5.31 Million
Q1 2022

May 12, 2022

BUY
$48.27 - $65.25 $5.31 Million - $7.18 Million
110,054 New
110,054 $6.13 Million
Q4 2021

Feb 10, 2022

SELL
$59.5 - $67.25 $22,372 - $25,286
-376 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$60.19 - $75.29 $3.47 Million - $4.35 Million
-57,721 Reduced 99.35%
376 $24,000
Q2 2021

Aug 11, 2021

SELL
$62.12 - $74.2 $1.67 Million - $1.99 Million
-26,878 Reduced 31.63%
58,097 $4.27 Million
Q1 2021

May 11, 2021

SELL
$57.98 - $73.08 $2.68 Million - $3.38 Million
-46,254 Reduced 35.25%
84,975 $5.22 Million
Q4 2020

Feb 11, 2021

SELL
$62.61 - $71.29 $1.38 Million - $1.57 Million
-22,016 Reduced 14.37%
131,229 $9.36 Million
Q3 2020

Nov 09, 2020

SELL
$51.39 - $72.41 $4.11 Million - $5.79 Million
-79,990 Reduced 34.3%
153,245 $10.7 Million
Q2 2020

Aug 12, 2020

BUY
$39.55 - $54.65 $9.22 Million - $12.7 Million
233,235 New
233,235 $12.4 Million
Q1 2020

May 11, 2020

SELL
$34.75 - $45.85 $7.07 Million - $9.33 Million
-203,548 Closed
0 $0
Q4 2019

Feb 06, 2020

BUY
$36.66 - $41.78 $7.46 Million - $8.5 Million
203,548 New
203,548 $8.26 Million
Q3 2019

Nov 07, 2019

SELL
$34.82 - $39.26 $4.46 Million - $5.02 Million
-127,964 Closed
0 $0
Q2 2019

Aug 08, 2019

SELL
$36.05 - $42.76 $412,772 - $489,602
-11,450 Reduced 8.21%
127,964 $4.8 Million
Q1 2019

May 09, 2019

SELL
$35.77 - $40.57 $1.71 Million - $1.94 Million
-47,857 Reduced 25.55%
139,414 $5.65 Million
Q4 2018

Feb 07, 2019

BUY
$31.89 - $38.44 $495,761 - $597,588
15,546 Added 9.05%
187,271 $7.06 Million
Q3 2018

Oct 30, 2018

BUY
$29.25 - $36.73 $973,995 - $1.22 Million
33,299 Added 24.06%
171,725 $5.94 Million
Q2 2018

Jul 24, 2018

BUY
$28.49 - $35.06 $2.34 Million - $2.88 Million
82,035 Added 145.48%
138,426 $4.46 Million
Q1 2018

Apr 12, 2018

SELL
$31.93 - $39.54 $1.15 Million - $1.42 Million
-35,906 Reduced 38.9%
56,391 $1.84 Million
Q3 2017

Oct 13, 2017

BUY
$30.11 - $37.72 $2.78 Million - $3.48 Million
92,297
92,297 $3.29 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.56B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.